Foods rich in flavan 3-ols are known to prevent cardiovascular diseases by reducing metabolic syndrome risks, such as hypertension, hyperglycemia, and dyslipidemia. However, the mechanisms involved in this reduction are unclear, particularly because of the poor bioavailability of flavan 3-ols. Recent metabolome analyses of feces produced after repeated ingestion of foods rich in flavan 3-ols may provide insight into the chronic physiological changes associated with the intake of flavan 3-ols. Substantial postprandial changes have been reported after flavan 3-ol ingestion, including hemodynamic and metabolic changes as well as autonomic and central nervous alterations. Taken together, the evidence suggests that flavan 3-ols have both postprandial and chronic effects, which could involve different or common mechanisms. In general, the accumulation of acute functional changes induces chronic physiological alteration. Therefore, this review highlights the postprandial action of flavan 3-ols in order to address the yet unknown mechanism(s) for their physiological function.
INTRODUCTION
Flavan 3-ols are a subclass of plant flavonoids that possess a diphenylpropane structure and are categorized as monomeric [eg, (þ)-catechin or (À)-epicatechin and its gallate type] or oligomeric catechins (eg, theaflavin and procyanidins). Extensive studies have been performed on the bioavailability and vascular functions of monomeric catechins in relation to their antiatherosclerotic effects. [1] [2] [3] The present review focuses mainly on oligomeric procyanidins because the physiological function of oligomeric procyanidins has attracted considerable attention in recent years. Foods rich in flavan 3-ols, such as tea, cocoa, red wine, grapes, and apples, could have substantial potential for managing cardiovascular health. [4] [5] [6] Recent metaanalyses have suggested that flavan 3-ol consumption reduces the risk of cardiovascular diseases, including coronary heart disease, myocardial infarction, and stroke. [7] [8] [9] In addition, numerous randomized controlled trials confirmed that dark chocolate containing large amounts of flavan 3-ols improves several conditions that contribute to metabolic syndrome, including hypertension, 10, 11 dyslipidemia, 12, 13 and glucose intolerance, 14, 15 and subsequent meta-analyses confirmed that dark chocolate can reduce the risk of cardiovascular disease. [16] [17] [18] [19] [20] In vitro evidence supports previous clinical data showing that flavan 3-ols affect nitric oxide (NO) production or breakdown, [21] [22] [23] as well as lipid metabolism 24, 25 and platelet function. 26, 27 Ingestion of flavan 3-ols has also been suggested to be inversely associated with diabetes risk. 28 The ingestion of flavan 3-ols has been reported to reduce peripheral insulin or glucose resistance in postmenopausal women, 29 hypertensive patients with impaired glucose tolerance, 15 and healthy volunteers. 30, 31 In addition, several animal studies have suggested that treatment with flavan 3-ols attenuates the risk factors for diabetes. [32] [33] [34] disorders and cognitive impairment in elder healthy volunteers, 35 although the mechanisms underlying the beneficial effect of flavan 3-ols is not well understood.
A recent comprehensive review on polyphenol and human health suggested that the mechanism for beneficial effect of flavan 3-ols has not been fully elucidated because of their poor bioavailability. 36 (þ)-Catechin and (À)-epicatechin are more readily absorbed than the other flavan 3-ols from the gastrointestinal tract, and almost all catechins are metabolized; therefore, unchanged forms are nearly absent in blood. 37 In contrast, other flavan 3-ols, including gallate-type catechins and oligomeric catechins, are rarely absorbed from the gut into the blood. [38] [39] [40] Consequently, flavan 3-ols pass from the upper digestive tract to the colon and are metabolized by gut microbiota to produce metabolites, primarily lactones and aromatic acids. 41 Flavan 3-ol metabolites could be absorbed into the systemic circulation and are expected to play a role in the physiological changes that occur in response to frequent consumption of flavan 3-ols. 42 In contrast, other studies have shown that flavan 3-ols exert postprandial actions on the hemodynamic, 43 metabolic, 44 and nervous systems, 45 which seem to be unrelated to their metabolites when the passage time in the intestine is taken into account. As such, flavan 3-ols may have both postprandial and chronic activities, and different or common mechanisms may underlie these effects. In general, the accumulation of acute functional changes induces chronic physiological alterations. Moreover, these hemodynamic, metabolic, and nervous system changes following the ingestion of flavan 3-ols are likely to occur cooperatively, not independently. Therefore, this review highlights the postprandial action of flavan 3-ols in order to address yet unknown mechanisms for the beneficial effect in human health.
FLAVAN 3-OLS AND BIOAVAILABILITY IN HUMANS
Flavan 3-ols are a subclass of plant flavonoids possessing a diphenylpropane structure and are categorized as monomers [eg, (þ)-catechin or (À)-epicatechin and its gallate type] or oligomers (eg, theaflavin and procyanidins) (Figure 1 ). They are included as antioxidants found in several plant-derived foods, such as tea, cocoa beans, grape (red wine), and apples. 39, [46] [47] [48] [49] Nongallate type catechins such as (À)-epicatechin are absorbed via the gastrointestinal tract and exist in the blood primarily as metabolites, often as conjugates with glucuronide and/or sulfate 50, 51 ( Figure 2 ). Approximately 20% of consumed (À)-epicatechin is absorbed, but unmetabolized (À)-epicatechin is nearly absent in the blood. The chemical structure of plasma (À)-epicatechin glucuronide differs between humans and murine animals 52 ; (À)-epicatechin glucuronides isolated from human plasma have lower antioxidative activity than those isolated from rat plasma. [52] [53] [54] Other flavan 3-ols (ie, gallate-type catechins and oligomeric catechins) are poorly absorbed in the gastrointestinal tract, because ATP-binding cassette (ABC) transporters, such as P-glycoprotein or a multidrug resistance protein (MRP), are involved in the elimination of flavan 3-ols from intestinal epithelial cells 55 ( Figure 2 ). In turn, gallate-type catechins and oligomeric catechins are present in the blood at very low concentrations. [37] [38] [39] [40] [56] [57] The bioavailability of flavan 3-ols may also be affected by the food matrix. Several previous studies reported that sugars enhance the absorption of flavan 3-ols in humans, [58] [59] [60] with the different sugar types that coexist with flavan 3-ols affecting the absorption rate. Whether the interaction of flavan 3-ols and protein affects the bioavailability of flavan 3-ols is still controversial. 61 Several in vitro studies have shown that several proteins, such as the major milk protein b-lactoglobulin 62 and albumin, 63 bind to flavan 3-ols tightly via covalent bonding. Serafini et al. 64 reported that milk protein reduces the intestinal absorption of flavan 3-ols. However, other studies have shown that they do not inhibit flavan 3-ol absorption. 59, 65, 66 Most of the remaining flavan 3-ols are metabolized by gut microbiota after passing from the upper digestive tract into the colon 41 ( Figure 2) . A recent radiolabel study in rats reported that procyanidin B2 metabolite is absorbed into the systemic circulation, with peak levels 5-7 hours after oral administration. 67 This finding is consistent with a study of the pig cecum system that demonstrated the degradation of procyanidins by microbiota 4-8 hours after consumption. 68, 69 Some of the main flavan 3-ol metabolites in humans are valerolactones, such as d-(3, 4-dihydroxyphenyl)-cvalerolactone, d-(3-hydroxyphenyl)-c-valerolactone, 70 5-(3,4-dihydroxyphenyl)-c-valerolactone, and 5-phenyl-c-valerolactone. 71 Phenolic acids, such as m-hydroxyphenylpropionic acid, 70 3-hydroxyphenyl propionic acid, 3-phenylpropionic acid, 72 hydroxyphenylpropionic acid, ferulic acid, 3,4-dihydroxyphenylacetic acid, m-hydroxyphenylacetic acid, vanillic acid, and m-hydroxybenzoic acid, 73 are also flavan 3-ol metabolites detected in extracts derived from human samples.
POSTPRANDIAL EFFECTS OF FLAVAN 3-OLS IN INTERVENTION TRIALS
Circulatory system
Several studies have described postprandial endothelial changes following the consumption of foods rich in flavan 3-ols. The elevation of flow-mediated dilatation (FMD), which occurs following the generation of endothelial-derived nitric oxide induced by shear stress, has been studied extensively. 74 In various studies, FMD was measured after the consumption of flavan 3-ol-rich foods for a specified period in healthy volunteers, [75] [76] [77] [78] [79] [80] smokers, 81 85, 87 FMD substantially increased between 1 and 2 hours after the ingestion of flavan 3-ol-rich foods, including dark chocolate, red wine, and pure (À)-epicatechin. The flavan 3-ol dose in these studies varied widely, from 176 mg 43 to 963 mg. 88 The activity of pure (À)-epicatechin was described in the 2 papers with contrasting conclusions, and thus the activity of (À)-epicatechin remains poorly understood. 93 In addition, portal or hepatic blood flow 91 and cerebral blood flow 92 have been reported to increase after the ingestion of flavan 3-ol-rich foods. A transient increase in blood pressure was demonstrated in the hepatic blood flow study. 91 These results indicate that oral administration of flavan 3-ols increases NO production by vascular endothelial cells directly, or indirectly through blood flow that transmits shear stress to the endothelium.
Two meta-analyses of randomized control intervention studies examining postprandial FMD alteration after ingestion of flavan 3-ols are available in the literature. 19, 94 These papers confirmed the postprandial increase in FMD following the ingestion of foods rich in flavan 3-ols. Interestingly, these papers also reported on medium-to long-term supplementation trials that suggested that changes in FMD were greater following a single oral administration than repeated ingestion of flavan 3-ol-rich foods. In contrast, recent meta-analyses have indicated that flavan 3-ol-rich food consumption for 2-18 weeks substantially reduces blood pressure in healthy volunteers or patients with moderate hypertension. 95 This hypotensive activity of flavan 3-ols seems to be reflected in the initial hemodynamic changes, but further studies are needed to explain the relevance of the acute and chronic effects of flavan 3-ols on the systemic circulation or microcirculation. 
Metabolic system
In oral glucose or meal tolerance tests 44, 93, 96, 97 in healthy individuals, postmenopausal woman, and diabetic patients, flavan 3-ols were reported to induce postprandial metabolic changes such as improvement of glucose or insulin tolerance (Table 2 44,93,96-98 ). In addition, energy expenditure as measured by respiratory analysis was substantially increased after obese individuals ingested 1 mg/kg body weight (À)-epicatechin. 98 These rapid metabolic changes were also observed 2-4 hours after ingestion of food rich in flavan 3-ol, and several in vitro studies found that high concentrations of flavan 3-ols pulled down in micelles 99,100 consisted of dietary fat and bile acid or inhibited glycolytic digestive enzymes. 101, 102 These actions observed in in vitro studies may reduce the increase in blood glucose or insulin.
Considerable studies have also assessed repeated treatment with flavan 3-ols in humans. Ingestion of flavan 3-ol-rich food for 4-12 weeks substantially altered plasma lipid concentrations, such as elevating highdensity lipoproteins and reducing low-density lipoproteins, 12, 103, 104 or improved insulin resistance. 15, 30, 83, 104 These chronic alterations on lipid metabolism and insulin resistance seem to result from the accumulation of postprandial metabolic changes following the ingestion of flavan 3-ols. However, more extensive studies are needed to elucidate the mechanism underlying metabolic alternation by flavan 3-ol ingestion.
Nervous system
Several studies have been reported regarding the alteration of both the autonomic and central nervous system following the ingestion of flavan 3-ols (Table 3 45, [105] [106] [107] [108] ). Spaak et al. 105 reported that the ingestion of red wine elevates plasma adrenaline levels and muscle sympathetic nerve activity, although these effects were not observed when only ethanol was consumed. In addition, working memory was suggested to be improved by the ingestion of chocolate in healthy individuals, 106, 107 and changes in these cerebral functions are considered to be related to changes in cerebral blood flow. A functional magnetic resonance imaging technique demonstrated that the elevation of blood oxygenation after ingestion of cocoa flavan 3-ols associates with the changes in cerebral blood flow. 45 Serial tasks, which are used to assess mental status in suspected cases of dementia, were improved 1 hour after supplementation with cocoa flavan 3-ols. 108 Repeated treatment with cocoa flavan 3-ols for 8-12 weeks in elderly individuals improved cognitive function and increased plasma brain-derived neurotrophic factor (BDNF) levels or improved insulin resistance. 109, 110 Acute and chronic changes in cognitive function seem to be closely associated with each other, and further consideration is thus needed as to how they cooperate in the nervous system.
POSTPRANDIAL EFFECTS OF FLAVAN 3-OLS IN ANIMAL STUDIES Circulatory system
Several papers have reported postprandial physiological changes following the ingestion of flavan 3-ol fractions or isolated flavan 3-ol by using experimental animals (Table 4) 111 -115,116-119,120,121 . These studies suggest that flavan 3-ols alter the level of NO in endothelial cells and influence hemodynamics, such as blood pressure, heart rate, and blood flow, in parallel. 111, 112 Comparisons of the acute hemodynamic changes by 14 polyphenolic compounds 113, 114 showed that mean blood pressure, heart rate, and blood flow in cremaster arterioles increase substantially shortly after the administration of a small amount of flavan 3-ol fraction (1-10 mg/kg). These changes are transient, and the increased blood pressure and heart rate return to baseline levels 60 minutes after ingestion. Phosphorylated endothelial nitric oxide synthase (eNOS) levels were substantially increased in aortas dissected 60 minutes after flavan 3-ol fraction ingestion compared with the vehicle treatment group, 112 and these effects were greater than those of isolated quercetin, hesperidin, trans-resveratrol, or curcumin. 113 As in the FMD intervention studies, flavan 3-ols appear to increase NO production from vascular endothelial cells by inducing eNOS phosphorylation. This effect was not dose-dependent because high amounts of flavan 3-ol fraction (100 mg/kg) did not induce eNOS phosphorylation or changes in blood pressure. 115 These results suggest that flavan 3-ols do not induce eNOS expression directly.
Vascular endothelial cells are continuously exposed to shear stress caused by blood flow, which activates several endothelial surface molecules, including platelet endothelial cell adhesion molecule (PECAM)-1, integrins, ion channels, and tyrosine kinase receptors. 122, 123 Shear stress can further promote phosphorylation of eNOS at Ser 1179 to directly activate eNOS and enhance NO production. Therefore, changes in NO levels induced by flavan 3-ols could affect systemic circulation in response to increased shear stress.
Metabolic system
Postprandial metabolic changes have also been reported in animal experiments (Table 4) . Insulin sensitivity detected after oral glucose or meal tolerance tests increased following the ingestion of flavan 3-ols derived from cocoa 116 and apples. 96, 117 In mice, the area under the plasma glucose curve after consumption of a meal or glucose alone (0-120 or 180 min) was reduced with preliminary supplementation of flavan 3-ols at a dose of 50-250 mg/kg. Interestingly, supplementation with 10 lg/kg of cinnamtannin A2 as a tetramer (À)-epicatechin substantially increased plasma insulin levels 60 minutes after ingestion. 118 This result suggests differences between flavan 3-ol constituents in terms of their ability to affect metabolism. Alterations in the glycemic response after ingestion of flavan 3-ols have been suggested to inhibit the expression of sodium-dependent glucose cotransporters (SGLUT) in the intestine 96 while enhancing the secretion of glucagon-like peptide-1 (GLP-1) 118 and accelerating glucose transporter-4 (GLUT-4) translocation in skeletal muscle. 116 It was found that flavan 3-ols enhance energy expenditure in mice, 119 with an elevation of phosphorylated AMP kinase (AMPK) in skeletal muscle and the messenger RNA expression of peroxisome proliferator-activated receptor c coactivator 1a (PGC-1a) and uncoupling protein 1 (UCP-1) in brown adipose tissue (BAT). These metabolic changes may lead to a reduction in risk of chronic metabolic diseases, such as dyslipidemia and diabetes.
Nervous system
Several animal studies have suggested a beneficial effect of flavan 3-ols on the central nervous system, such as on memory or cognitive function, after repeated treatment with flavan 3-ols. [124] [125] [126] These studies also indicate improved brain function by the ingestion of flavan 3-ols, which results in elevation of BDNF, decrease of monoamine metabolism, the downregulation of neurodegeneration genes in the hippocampus, and/or increase of cerebral blood flow. However, the postprandial alteration of these events by flavan 3-ols may be little as compared with the changes of the central nervous system following chronic ingestion of flavan 3-ols.
Several murine studies have evaluated the changes in the autonomic nervous system brought on by ingestion of flavan 3-ols. Tanida et al. 120 reported that the activity of sympathetic nerves innervating BAT substantially enhances increased BAT thermogenesis soon after intraduodenal injection of flavangenol as a flavan 3-ol-rich supplement. The stimulation of sympathetic nerves enhances the release of catecholamines (CA) from the terminal of the sympathetic nerve to the target organ, such as BAT, and from the adrenal medulla to the circulatory blood flow. 127, 128 Transient elevation of plasma adrenaline levels was also observed after ingestion of flavan 3-ol fraction.
119
Hemodynamics 129 and energy metabolism 130 are tightly controlled by the autonomic nervous system. Neural adrenergic factors regulate metabolic pathways, such as glycolysis in the liver via the b2 adrenergic receptor (AR) 131, 132 or thermogenesis in BAT via the b3 AR. 133 The b3 AR is expressed in adipose tissue, particularly BAT, and directly induces UCP-1 via PGC1a. 134, 135 Stable blood pressure and heart rate can be maintained through rapid hemodynamic changes regulated by ARs. 136 Plasma adrenaline secreted from the adrenal medulla also indirectly induces changes in skeletal muscle metabolism via the b2 AR. The b2 AR expressed in skeletal muscle regulates glycolysis through AMPKa phosphorylation, followed by GLUT-4 translocation, 137, 138 and lipolysis through PGC-1a upregulation. 139, 140 In addition, b2 AR agonists, including clenbuterol 141 and formoterol, 142 can improve muscle metabolism by upregulating PGC-1a expression and activating Akt/mTOR pathways. Given these roles, whether AR activity is involved in the postprandial physiological changes that occur after the ingestion of flavan 3-ols was examined. In the metabolic study, pretreatment of mice with b2 AR blocker butoxamine before the consumption of 10 mg/ kg of flavan 3-ols prevented an increase in energy expenditure and levels of phosphorylated AMPKa in the gastrocnemius. 121 Furthermore, the b3AR blocker SR52930 suppressed flavan 3-ol-induced increases in PGC-1a or UCP-1 expression in BAT.
In the hemodynamic study, small amounts of flavan 3-ols (1-10 mg/kg) transiently increased blood pressure and heart rate, but high doses (100 mg/kg) did not. Pretreatment of mice with a nonspecific adrenaline blocker, such as carvedilol, reduced the changes induced by low doses of flavan 3-ols. Therefore, the hemodynamic changes following the consumption of low doses of flavan 3-ols could be attributed to adrenomimetic effects. 114 The treatment of rats with a combination of 100 mg/kg of flavan 3-ols and a2 adrenergic Figure 3 Possible mechanisms of postprandial physiological alteration following flavan 3-ol ingestion. Flavan 3-ols stimulate sympathetic nerves through the central nervous system while passing through the gut. Consequently, noradrenaline is secreted from the sympathetic nerve to the target organ, such as peripheral arteries, the heart, or brown adipose tissue (BAT). The resulting activation of adrenergic receptors (ARs) expressed in each organ dynamically induces hemodynamic and metabolic changes. Sympathomimetic action also increases CA secretion from the adrenal medulla into the bloodstream. In skeletal muscle, bAR is activated and increases metabolic changes. Moreover, excessive sympathetic nerve stimulation induced by high doses of flavan 3-ols is suppressed by the negative feedback system in the central nervous system. Abbreviations: AMPK, AMP kinase; eNOS, endothelium nitric oxide synthase; GLUT-4, glucose transpoter-4; PGC-1a, peroxisome proliferator-activated receptor c coactivator 1 a; UCP-1, uncoupling protein-1.
blocker yohimbine, which inhibits excessive sympathetic nerve stimulation of the vasomotor center in the medulla oblongata, caused a noticeable increase in hemodynamic changes, such as elevated blood pressure and heart rate. These results may suggest that the consumption of high amounts of flavan 3-ols (100 mg/kg) can induce excessive neural stimulation, resulting in negative feedback to the vasomotor center to reduce peripheral changes, such as transient increases in blood pressure and heart rate. These observations indicate that neural adrenergic factors are essential mediators of the postprandial physiological alterations induced by flavan 3-ol consumption (Figure 3) . Flavan 3-ols stimulate sympathetic nerves through the central nervous system while passing through the gut. Consequently, noradrenaline is secreted from the sympathetic nerve to the target organ, such as peripheral arteries, the heart, or BAT. The resulting activation of ARs expressed in each organ dynamically induces hemodynamic and metabolic changes. Sympathomimetic action also increases CA secretion from the adrenal medulla into the bloodstream. In skeletal muscle, bAR is activated, resulting in metabolic changes. Moreover, excessive sympathetic nerve stimulation induced by high doses of flavan 3-ols is suppressed by the negative feedback system in the central nervous system. However, the mechanism through which flavan 3-ol ingestion stimulates sympathetic nerve activity is unknown. Further studies are required to clarify the mechanisms involved, including braingastrointestinal axis stimulation by flavan 3-ols.
CONCLUSION
The stimulation of sympathetic nerve activity seems to be involved in postprandial hemodynamic, metabolic, and nervous system alteration following the ingestion of flavan 3-ols. All of the postprandial actions of flavan 3-ols in these systems are likely to lead to beneficial effect in chronic impairment, such as reduced cardiovascular and metabolic diseases, and possibly a reduction in the decline of cognitive function. Sympathetic nervous stimulation has been well documented to be induced by the response against physical stress, such as cold 143, 144 and exercise. 145, 146 Transient cold exposure induces BAT thermogenesis via b3 AR. 147 The duration of cold exposure promotes not only the activation of BAT but also the differentiation from white adipose to beige adipose. 148 Both adipose tissue types are suggested to be important in regulating body temperature and body weight because of the expenditure of chemical energy to produce heat. In addition, at the beginning of exercise, transient hemodynamic changes, such as elevation of blood pressure, heart rate, and blood flow, along with shear stress to arterioles, are induced. 149 Repeating these hemodynamic events produces vascular reconstruction and hypotension via the induction of eNOS expression and the secretion of vascular endothelial growth factor. 146 The hypotensive effect of exercise is attributable to these mechanisms. Moreover, recent evidence suggests that enhancement of cerebral blood flow by exercise increases the release of BDNF from the brain, consequently conveying a protective effect against the decline of cognitive function. 150, 151 Therefore, it is rational to believe that these hemodynamic, metabolic, and nervous system changes occur cooperatively rather than independently.
Activation of the brain-gastrointestinal axis may play a part in this postprandial change after the ingestion of flavan 3-ols because flavan 3-ols can reach functional proteins located in the gastrointestinal mucosal cells despite little transfer into the circulation. Studies of the interaction between flavan 3-ols and the gut should be evaluated to identify the target sites of flavan 3-ols in the digestive tract.
Acknowledgments
Author contributions. N. Osakabe performed the data searches and data extraction and conducted the data analysis and wrote the article. All authors contributed to the editing of the manuscript and share responsibility for the final content. All authors read and approved the final manuscript. 
